BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
114 hedge funds and large institutions have $1.43B invested in Audentes Therapeutics, Inc in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 123 → 114 (-9)
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
Holders
114
Holding in Top 10
4
Calls
$2.85M
Puts
$2.05M
Top Buyers
| 1 | +$44.7M | |
| 2 | +$11.9M | |
| 3 | +$10M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$7.52M |
| 5 |
CC
Casdin Capital
New York
|
+$6.93M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$22M | |
| 3 | -$17.2M | |
| 4 |
O
OrbiMed
New York
|
-$17.2M |
| 5 |
Millennium Management
New York
|
-$12.9M |